Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release

Area of Science:

• Neuroscience
• Neuropharmacology
• Dopamine Signaling

Background:

• The mesolimbic dopamine (DA) system, originating in the ventral tegmental area (VTA), is crucial for reward and motivation.
• Understanding the neurochemical regulation of DA release in the nucleus accumbens (ACC) is vital for comprehending motivated behaviors.

Purpose of the Study:

• To investigate the influence of serotonin (5-HT), glutamate, and GABA on dopamine release in the rat nucleus accumbens (ACC).
• To elucidate the specific receptor subtypes involved in serotonin's modulation of the mesolimbic dopamine system.

Main Methods:

• Utilized a push-pull perfusion technique in freely moving rats to measure neurotransmitter levels in the ACC.
• Microinfused agents including glutamate, muscimol (a GABA agonist), and serotonin (5-HT) into the VTA.

Main Results:

• Glutamate and 5-HT microinfusion into the VTA significantly increased DOPAC and HVA levels in the ACC, indicating enhanced DA turnover.
• Muscimol significantly decreased DA and DOPAC levels in the ACC, suggesting GABAergic inhibition.
• A nonselective 5-HT1 agonist mimicked 5-HT's effect, but a selective 5-HT1A agonist did not, implicating 5-HT1B receptors.

Conclusions:

• Ventral tegmental area (VTA) serotonin (5-HT) innervations exert an excitatory effect on the mesolimbic dopamine (DA) system projecting to the nucleus accumbens (ACC), likely via 5-HT1B receptors.
• The mesolimbic DA system is subject to regulation by glutamatergic and GABAergic inputs acting on the VTA.